Pricing Supply and Viability Subgroup 13 February 2018 Communique
Page last updated: 10 October 2018
The Pricing Supply and Viability Subgroup met on 13 February 2018.
Attendees included representatives from the Generic and Biosimilar Medicines Association (GBMA), industry and the Department of Health.
This meeting provided the opportunity for members to identify common themes and areas to improve the pricing, supply and viability of medicines in Australia.
Members will seek endorsement of the updated scope outlining the role, membership and forward work plan for the subgroup at the next meeting of the Generic Medicines Working Group in March 2018. The activities of this subgroup are consistent with the Strategic Agreement between the Australian Government and GBMA.
PDF version of Pricing Supply and Viability Subgroup 13 February 2018 Communique (153 KB)